Skip to content

ARCH Venture Partners XII, L.P.

Reporting owner on Forms 3, 4 and 5, CIK 1979765.

ARCH Venture Partners XII, L.P. reported on 1 issuer in 4 filings, the latest a 13D/A filed 2026-11-13.

Issuers

IssuerRoles in the latest filingFilingsLast filed
CITY THERAPEUTICS, INC. CIK 214385010% owner22026-10-19

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
CITY THERAPEUTICS, INC. Common Stock2026-10-19C converted+3,294,9006,013,192Form 4
CITY THERAPEUTICS, INC. Common Stock2026-10-19C converted+5,482,30911,495,501Form 4
CITY THERAPEUTICS, INC. Common Stock2026-10-19C converted+2,027,00613,522,507Form 4
CITY THERAPEUTICS, INC. Common Stock2026-10-19P bought+170,000$1813,692,507Form 4
CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative2026-10-19C converted-3,000,000$00Form 4
CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative2026-10-19C converted-4,991,633$00Form 4
CITY THERAPEUTICS, INC. Series B convertible preferred stock, derivative2026-10-19C converted-1,845,585$00Form 4
CITY THERAPEUTICS, INC. Common Stock, holding 2,718,292Form 3
CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative, holding Form 3
CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative, holding Form 3
CITY THERAPEUTICS, INC. Series B convertible preferred stock, derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0001193125-26-460600 PRME2026-11-13
13D 0001193125-26-432028 CTY2026-10-26
Form 4 0001104659-26-116966 CITY THERAPEUTICS, INC.2026-10-19
Form 3 0001104659-26-116360 CITY THERAPEUTICS, INC.2026-10-15